Fipronil-(S)-Methoprene Ceva Spot-on Solution for Dogs 40-60 kg

País: Reino Unido

Língua: inglês

Origem: VMD (Veterinary Medicines Directorate)

Ingredientes ativos:

(S)-Methoprene, Fipronil

Disponível em:

Ceva Sante Animale

Código ATC:

QP53AX65

DCI (Denominação Comum Internacional):

(S)-Methoprene, Fipronil

Forma farmacêutica:

Spot-on solution

Tipo de prescrição:

POM-V - Prescription Only Medicine – Veterinarian

Grupo terapêutico:

Dogs

Área terapêutica:

Ectoparasiticide

Status de autorização:

Expired

Data de autorização:

2015-08-24

Características técnicas

Revised: July 2020
AN: 01870/2019
Page 1 of 7
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Fipronil-(S)-Methoprene Ceva Spot-on Solution for Dogs 40-60 kg
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 4.24 ml pipette contains:
ACTIVE SUBSTANCES:
Fipronil
720.80 mg
(S)-methoprene
360.4 mg
EXCIPIENTS:
Butylhydroxyanisole E320
0.848 mg
Butylhydroxytoluene E321
0.848 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Spot-on solution.
Clear yellow solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs 40-60 kg
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
-
Treatment and prevention of flea and/or tick infestations.
-
Treatment and prevention of flea infestations (_Ctenocephalides
_spp.). Immediate
insecticidal efficacy against new infestations with adult fleas
persists for 9 weeks.
Prevention of the multiplication of fleas by inhibiting the hatching
of flea eggs
(ovicidal activity) and the development of flea eggs into adult fleas
for 8 weeks
after application.
-
Treatment
and
prevention
of
tick
infestation
(_Dermacentor _
_reticulatus_,
_Rhipicephalus_ _sanguineus_). The product has immediate and
persistent acaricidal
efficacy for 6 weeks after application.
The product can be used as part of a treatment strategy for the
control of Flea Allergy
Dermatitis (FAD).
Revised: July 2020
AN: 01870/2019
Page 2 of 7
4.3
CONTRAINDICATIONS
Do not use on rabbits, as adverse reactions even mortality could
occur.
Do not use in cases of hypersensitivity to the active substance or to
any of the
excipients.
Do not use on sick (e.g. systemic disease, fever) or convalescent
animals.
This product is specifically developed for dogs. Do not use in cats,
as this could lead
to overdosing.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
All stages of fleas can infest the dog’s basket, bedding, and
regular resting areas
such as carpets and soft furnishings. In cases of massive flea
infestation and at the
beginning of the control measures these areas should be treated wit